References
- Smith, Leah, et al.A 2018 Special Report on Cancer Incidence by Stage.Toronto.Canadian Cancer Society; 2018.
- “What Is Cancer?” National Cancer Institute , National Institutes of Health , 9 Feb. 2015, www.cancer.gov/about-cancer/understanding/what-is-cancer.
- “What Is Melanoma Skin Cancer? .” Canadian Cancer Society, Canadian Cancer Society, 2018, www.cancer.ca/en/cancer-information/cancer-type/skin-melanoma/melanoma/?region=on.
- “Using Research Organisms to Study Health and Disease.” National Institute of General Medical Sciences, U.S. Department of Health and Human Services, www.nigms.nih.gov/Education/Pages/modelorg_factsheet.aspx.
- Chakraborty, C, et al. “Zebrafish: a Complete Animal Model for in Vivo Drug Discovery and Development.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Feb. 2009, www.ncbi.nlm.nih.gov/pubmed/19275547.
- Spitsbergen, Jan M., and Michael L. Kent. “The State of the Art of the Zebrafish Model for Toxicology and Toxicologic Pathology Research–Advantages and Current Limitations.” Toxicologic Pathology, vol. 31, no. 1, Jan. 2003, pp. 62–87., doi:10.1080/01926230309774.
- Fields, S. “CELL BIOLOGY: Whither Model Organism Research?” Science, vol. 307, no. 5717, 2005, pp. 1885–1886., doi:10.1126/science.1108872.
- Kari, G, et al. “Zebrafish: An Emerging Model System for Human Disease and Drug Discovery.” Clinical Pharmacology & Therapeutics, vol. 82, no. 1, Sept. 2007, pp. 70–80., doi:10.1038/sj.clpt.6100223.
- Mestas, J., and C. C. W. Hughes. “Of Mice and Not Men: Differences between Mouse and Human Immunology.” The Journal of Immunology172, no. 5 (2004): 2731-738. doi:10.4049/jimmunol.172.5.2731.
- Zhang, Wei, et al. “Mouse Models for Cancer Research.” Chinese Journal of Cancer, vol. 30, no. 3, Mar. 2011, pp. 149–52. PubMed Central, doi:10.5732/cjc.011.10047.
- SETDB1 Gene – GeneCards | SETB1 Protein | SETB1 Antibody. https://www.genecards.org/cgi-bin/carddisp.pl?gene=SETDB1&keywords=SETDB1. Accessed 7 Dec. 2018
- Ceol, Craig J., et al. “The SETDB1 Histone Methyltransferase Is Recurrently Amplified in and Accelerates Melanoma.” Nature, vol. 471, no. 7339, Mar. 2011, pp. 513–17. PubMed Central, doi:10.1038/nature09806.